ArticleFrontiers in immunology2025

LST1: a novel biomarker for efferocytosis in the co-occurrence of type 2 diabetes mellitus and clear cell renal cell carcinoma.

Yuru Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.